Loading clinical trials...
Loading clinical trials...
A Phase Ia Single-Center, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Trial of GenSci142 Administered in Single Ascending Doses in Healthy Chinese Women
Conditions
Interventions
GenSci142
Placebo GenSci142
Locations
1
China
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Start Date
December 1, 2025
Primary Completion Date
September 1, 2026
Completion Date
December 1, 2026
Last Updated
December 24, 2025
NCT07394777
NCT01829204
NCT04046900
NCT06472765
NCT06469164
NCT05796921
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions